Panitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Cancer of the Gastroesophageal Junction

NCT00757172 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Adenocarcinoma of the Gastroesophageal Junction
Esophageal Cancer

Interventions

BIOLOGICAL: panitumumab
DRUG: cisplatin
DRUG: docetaxel
PROCEDURE: neoadjuvant therapy
PROCEDURE: therapeutic conventional surgery
RADIATION: radiation therapy

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]
[object Object]